P/B
0,6
Oramed Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
$195.1M
Market Cap • 9/29/2026
2002
(24 years)
Founded
2004
(22 years ago)
IPO
NASDAQ
Listing Exchange
Israel
Country
Valuation
P/S
—
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
1,1
BVPS
7,6
EPS
4,1
Market Cap
Market Cap
195,1M
EV
145,2M
EV/Revenue
0
EV/EBITDA
-10,1
EV/EBIT
-10
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
2,2%
Total Yield
2,2%
Payout
0%
Retained Earnings
-7M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
7,4%
Capex/OCF
-0,2%
SBC/OCF
—
% PPE
0,3%
% Goodwill
0%
ROE
74,2%
ROIC
—
Growth
CAGR Revenue 5Y
-100%
CAGR Net Income 5Y
62,4%
CAGR OCF 5Y
-19,3%
Leverage
N.D./EBITDA
3,5
Debt/Equity
0%
Current Ratio
5
Quick Ratio
4,8
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!